CAS 1233363-33-1

Pegcantratinib

CAS : 1233363-33-1

Pegcantratinib is a pyrimidine compound that binds to tropomyosin and inhibits the activity of tumour suppressor genes. It has been shown to inhibit the proliferation of cancer cells in vitro, and exhibits anti-inflammatory effects in an animal model of inflammatory skin disease. Pegcantratinib can be used as an analytical method for identifying molecules in biological samples, such as inflammatory skin diseases. This drug has also been shown to bind to matrix proteins with high affinity, which may lead to problems with sample preparation methods.

Formule : C₃₂H₂₈N₄O₇

Degré de pureté : Min. 95%

Masse moléculaire : 580.6 g/mol

Ref: 3D-IZB36333

Pegcantratinib

CAS : 1233363-33-1

Pegcantratinib is a tropomyosin receptor kinase inhibitor for treatment for inherited CYLD defective skin tumours.

Formule : C₃₂H₂₈N₄O₇

Couleur et forme : Solid

Masse moléculaire : 580.59

Ref: TM-T71171